Overview
- Editors:
-
-
Ekaterini Tiligada
-
Department of Pharmacology Medical School, National and Kapodistrian University of Athens, Athens, Greece
-
Madeleine Ennis
-
Centre for Experimental Medicine, School of Medicine, Dentistry and Biomedical Sciences, Queen’s University Belfast, Belfast, Northern Ireland, United Kingdom
- Illustrates current, state-of-the-art techniques in histamine research
- Features methodologies for the investigation of pharmacological properties and the therapeutic exploitation of histamine receptors and their ligands
- Includes explorations in both laboratory and clinical settings
- Includes supplementary material: sn.pub/extras
Access this book
Other ways to access
About this book
This book illustrates the current state-of-the-art in histamine research, with a focus on the appropriate methodologies to investigate the pharmacological properties and the therapeutic exploitation of HRs and their ligands. In addition, the range of techniques described provides an introduction to complementary cross-methodological disciplines beyond these fields. This multi-disciplinary approach is required to define the ‘decision gates’ that determine the development of more effective and safer therapeutic options for many forms of highly prevalent and debilitating diseases, such as asthma, dementias, dermatitis, and arthritis. Written for the Methods in Pharmacology and Toxicology series, chapters concentrate on practical, hands-on protocols from experts in the techniques.
Authoritative and thorough, Histamine Receptors as Drug Targets seeks to aid pharmacologists, biochemists, drug discovery researchers, molecular biologists, chemists, toxicologists, lab scientists, medical doctors, principle investigators, research scientists, lab directors and technicians, as well as graduate students around the world in pursuing the study of this vital scientific area.
Similar content being viewed by others
Article
Open access
20 October 2023
Table of contents (17 protocols)
-
-
- Stephany Micallef, Astrid Sasse
Pages 1-18
-
- Fiona C. Shenton, Natasha Lethbridge, Paul L. Chazot
Pages 19-47
-
- Tadeusz Karcz, Urszula Cichoń, Katarzyna Kieć-Kononowicz
Pages 49-66
-
- Natalia C. Fernández, Carina Shayo, Carlos Davio, Federico Monczor
Pages 67-114
-
- Reggie Bosma, Tamara A. M. Mocking, Rob Leurs, Henry F. Vischer
Pages 115-155
-
- Eléonore W. E. Verweij, Rob Leurs, Henry F. Vischer
Pages 157-181
-
- Ondřej Vašíček, Tomáš Perečko, Viera Jančinová, Silvia Pažoureková, Radomír Nosáľ, Milan Číž
Pages 183-208
-
- Marek Grosicki, Katarzyna Kieć-Kononowicz
Pages 209-232
-
- Kristine Roßbach, Hanna Köchling, Tomoki Fukuyama, Jenny Wilzopolski, Manfred Kietzmann, Wolfgang Bäumer
Pages 233-262
-
- Alessandro Pini, Eleonora Veglia, Cristina Grange, Arianna Carolina Rosa
Pages 263-308
-
- Alessandro Pini, Eleonora Veglia, Arianna Carolina Rosa
Pages 309-352
-
- Diego J. Martinel Lamas, Melisa B. Nicoud, Helena Sterle, Graciela P. Cricco, Gabriela A. Martin, Graciela A. Cremaschi et al.
Pages 353-387
-
- Carlos Acosta-Andrade, José L. Urdiales, Ignacio Fajardo, Francisca Sánchez-Jiménez
Pages 389-410
-
- Dimitrios P. Besinis, Maria C. Anagnostouli
Pages 411-431
-
- Christopher Koulias, Xenophon Aggelides, Caterina Chliva, Michael Makris
Pages 433-472
-
- Chrysovalantis Korfitis, Efstathios Rallis, Dimitrios Rigopoulos
Pages 473-487
-
- Ekaterini Tiligada, Maria Kakolyri, Madeleine Ennis
Pages 489-508
-
Back Matter
Pages 509-517
Editors and Affiliations
-
Department of Pharmacology Medical School, National and Kapodistrian University of Athens, Athens, Greece
Ekaterini Tiligada
-
Centre for Experimental Medicine, School of Medicine, Dentistry and Biomedical Sciences, Queen’s University Belfast, Belfast, Northern Ireland, United Kingdom
Madeleine Ennis